<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Chordal papillary integrity is crucial for a good left ventricular performance following mitral valve surgery </plain></SENT>
<SENT sid="1" pm="."><plain>From June 1991-July 1993 (2 years), 200 mitral surgeries were performed by the authors out of which MVR were done by preserving <z:hpo ids='HP_0000001'>all</z:hpo> chordae tendineae in 36 patients (18%), ages 11-64 years (mean 36 +/- 13.2 SD), female to male ratio 3:1, New York Heart Association (NYHA) functional class III-IV </plain></SENT>
<SENT sid="2" pm="."><plain>Preoperative workup revealed pure <z:hpo ids='HP_0001718'>mitral stenosis</z:hpo> (MS) in 12 patients (33%), <z:hpo ids='HP_0001653'>mitral regurgitation</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e>) in 16 (44%), MS + <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> in 7 (19%), MS + <z:hpo ids='HP_0001659'>aortic regurgitation</z:hpo> (AR) in 4 (11%), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> + <z:hpo ids='HP_0001684'>secundum atrial septal defect</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">ASD</z:e>) in 2 (6%), <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> + <z:mp ids='MP_0010404'>primum ASD</z:mp> in 1, <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MR</z:e> + <z:hpo ids='HP_0001677'>coronary artery disease</z:hpo> (CAD) in 1 (3%) and moderate to severe <z:hpo ids='HP_0002092'>pulmonary hypertension</z:hpo> in <z:hpo ids='HP_0000001'>all</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Twenty-two patients (61%) had MVR only, 4 (11%) had MVR + aortic valve replacement (AVR), 10 (29%) had MVR + tricuspid annuloplasty (TVA), MVR + <z:mp ids='MP_0010405'>secundum ASD</z:mp> closure in 2 (6%), MVR+<z:mp ids='MP_0010404'>primum ASD</z:mp> closure in 1 (3%) and MVR + coronary artery bypass grafting (CABG) in 1 (3%) </plain></SENT>
<SENT sid="4" pm="."><plain>Bioprosthesis used were: St </plain></SENT>
<SENT sid="5" pm="."><plain>Vincents 17 (47%) and Carpentier <z:e sem="disease" ids="C0152096" disease_type="Disease or Syndrome" abbrv="">Edwards</z:e> 2 (6%) </plain></SENT>
<SENT sid="6" pm="."><plain>Mechanical valves used were: St </plain></SENT>
<SENT sid="7" pm="."><plain>Jude's 1 (3%), Bjork-Shiley 2 (6%), St </plain></SENT>
<SENT sid="8" pm="."><plain>Vincents 5 (14%), CarboMedics 9 (25%) </plain></SENT>
<SENT sid="9" pm="."><plain>Success of the procedure were accomplished in <z:hpo ids='HP_0000001'>all</z:hpo> (100%) and was judged by extubation period of 6-18 hours, <z:mp ids='MP_0004013'>decreased pulmonary artery pressure</z:mp>, good prosthetic function and adequate ventricular performance by subsequent echocardiographic assessments </plain></SENT>
<SENT sid="10" pm="."><plain>There were no early (&lt; 30 days) mortality </plain></SENT>
<SENT sid="11" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients showed NYHA functional class I-II except in one with <z:e sem="disease" ids="C0024796" disease_type="Disease or Syndrome" abbrv="MFS|MFS1">Marfan syndrome</z:e>.(ABSTRACT TRUNCATED AT 250 WORDS) </plain></SENT>
</text></document>